Literature DB >> 8813725

Interactions among Janus kinases and the prolactin (PRL) receptor in the regulation of a PRL response element.

J Gao1, J P Hughes, B Auperin, H Buteau, M Edery, H Zhuang, D M Wojchowski, N D Horseman.   

Abstract

PRL regulates milk gene expression, at least in part, by activating JAK2 kinase and STAT5 (signal transducer and activator of transcription 5), initially termed mammary gland factor (MGF). These experiments were initiated to gain a better understanding of the mechanisms of transcriptional activation via PRL receptor (PRL-R) signaling. Binding of PRL to the recombinant pigeon PRL-R-activated transcription driven by a 2.8 kbp 5'-fragment of the rat beta-casein gene. PRL enhanced the expression of chimeric reporters containing the beta-casein PRL response element (PRE), but not the c-fos sis-inducible element, when the reporters were transfected into Chinese hamster ovary cells with the PRL-R. Wild type receptor, which contains a duplication of the entire extracellular ligand-binding domain, was only slightly more effective than a truncation mutant with a single extracellular domain. Transfection with either JAK1, JAK2, or JAK3 increased basal transcription through both the PRE and sis-inducible element. Coexpression of JAK2 with PRL-R resulted in amplification of the induction of the PRE by PRL, whereas JAKs 1 and 3 did not amplify the PRL effect. Overexpression of JAK2 mutants blocked PRE activation by PRL. Mutant JAK2 also interfered with PRE activation by JAK3 but did not affect JAK1's stimulatory effect.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8813725     DOI: 10.1210/mend.10.7.8813725

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  8 in total

1.  Prolactin-regulated pim-1 transcription: identification of critical promoter elements and Akt signaling.

Authors:  Nithya Krishnan; Huiqi Pan; Donna J Buckley; Arthur Buckley
Journal:  Endocrine       Date:  2003 Feb-Mar       Impact factor: 3.633

2.  Prolactin signals via Stat5 and Oct-1 to the proximal cyclin D1 promoter.

Authors:  Jennifer L Brockman; Linda A Schuler
Journal:  Mol Cell Endocrinol       Date:  2005-07-15       Impact factor: 4.102

3.  Aberrantly high expression of the CUB and zona pellucida-like domain-containing protein 1 (CUZD1) in mammary epithelium leads to breast tumorigenesis.

Authors:  Janelle Mapes; Lavanya Anandan; Quanxi Li; Alison Neff; Charles V Clevenger; Indrani C Bagchi; Milan K Bagchi
Journal:  J Biol Chem       Date:  2018-01-10       Impact factor: 5.157

Review 4.  The role of prolactin in mammary carcinoma.

Authors:  Charles V Clevenger; Priscilla A Furth; Susan E Hankinson; Linda A Schuler
Journal:  Endocr Rev       Date:  2003-02       Impact factor: 19.871

5.  High prevalence of MMTV-like env gene sequences in gestational breast cancer.

Authors:  Y Wang; S M Melana; B Baker; I Bleiweiss; M Fernandez-Cobo; J F Mandeli; J F Holland; B G T Pogo
Journal:  Med Oncol       Date:  2003       Impact factor: 3.064

6.  Multiple Endocrine Disruption by the MET/ALK Inhibitor Crizotinib in Patients With Non-small Cell Lung Cancer.

Authors:  Robert M Sargis; Ravi Salgia
Journal:  Am J Clin Oncol       Date:  2015-10       Impact factor: 2.339

7.  Characterization of PRLR and PPARGC1A genes in buffalo (Bubalus bubalis).

Authors:  Ruheena Javed; Sanjeev K Gautam; Ramesh K Vijh; Madhu S Tantia
Journal:  Genet Mol Biol       Date:  2011-10-01       Impact factor: 1.771

8.  CUZD1 is a critical mediator of the JAK/STAT5 signaling pathway that controls mammary gland development during pregnancy.

Authors:  Janelle Mapes; Quanxi Li; Athilakshmi Kannan; Lavanya Anandan; Mary Laws; John P Lydon; Indrani C Bagchi; Milan K Bagchi
Journal:  PLoS Genet       Date:  2017-03-09       Impact factor: 5.917

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.